Kerr W. Holbrook's most recent trade in Avanos Medical Inc was a trade of 49,088 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on March 7, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avanos Medical Inc | Kerr W. Holbrook | SVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 49,088 | 49,088 | - | - | Employee Stock Option (right to buy) | |
| Avanos Medical Inc | Kerr W. Holbrook | SVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 22,877 | 98,860 (0%) | 0% | 0 | Common Stock | |
| Avanos Medical Inc | Kerr W. Holbrook | SVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 15.25 per share. | 06 Mar 2025 | 7,000 | 82,047 (0%) | 0% | 15.3 | 106,778 | Common Stock |
| Avanos Medical Inc | Kerr W. Holbrook | SVP, Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.30 per share. | 06 Mar 2025 | 3,590 | 75,983 (0%) | 0% | 15.3 | 54,927 | Common Stock |
| Avanos Medical Inc | Kerr W. Holbrook | SVP, Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.30 per share. | 06 Mar 2025 | 2,474 | 79,573 (0%) | 0% | 15.3 | 37,852 | Common Stock |
| Avanos Medical Inc | Kerr W. Holbrook | SVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 5,145 | 92,393 (0%) | 0% | 0 | Common Stock | |
| Avanos Medical Inc | Kerr W. Holbrook | SVP, Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.13 per share. | 04 Mar 2025 | 1,803 | 90,590 (0%) | 0% | 15.1 | 27,279 | Common Stock |
| Avanos Medical Inc | Kerr W. Holbrook | SVP, Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.13 per share. | 04 Mar 2025 | 1,543 | 89,047 (0%) | 0% | 15.1 | 23,346 | Common Stock |
| Avanos Medical Inc | Kerr W. Holbrook | SVP, Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.09 per share. | 18 Mar 2024 | 2,840 | 86,131 (0%) | 0% | 19.1 | 54,216 | Common Stock |
| Avanos Medical Inc | Kerr W. Holbrook | SVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2024 | 2,531 | 89,727 (0%) | 0% | 0 | Common Stock | |
| Avanos Medical Inc | Kerr W. Holbrook | SVP, Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.09 per share. | 18 Mar 2024 | 756 | 88,971 (0%) | 0% | 19.1 | 14,432 | Common Stock |
| Avanos Medical Inc | Kerr W. Holbrook | SVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 19.14 per share. | 06 Mar 2024 | 36,573 | 89,814 (0%) | 0% | 19.1 | 700,007 | Common Stock |
| Avanos Medical Inc | Kerr W. Holbrook | SVP, Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.00 per share. | 06 Mar 2024 | 2,618 | 87,196 (0%) | 0% | 19 | 49,742 | Common Stock |
| Avanos Medical Inc | Kerr W. Holbrook | SVP, Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.76 per share. | 05 Mar 2024 | 1,502 | 52,310 (0%) | 0% | 18.8 | 28,178 | Common Stock |
| Avanos Medical Inc | Kerr W. Holbrook | SVP, Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.97 per share. | 08 May 2023 | 1,772 | 53,812 (0%) | 0% | 24.0 | 42,475 | Common Stock |
| Avanos Medical Inc | Kerr W. Holbrook | SVP, GM Chronic Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 24,233 | 57,097 (0%) | 0% | 0 | Common Stock | |
| Avanos Medical Inc | Kerr W. Holbrook | SVP, GM Chronic Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.62 per share. | 06 Mar 2023 | 1,513 | 55,584 (0%) | 0% | 29.6 | 44,815 | Common Stock |
| Avanos Medical Inc | Kerr W. Holbrook | SVP, GM Chronic Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.75 per share. | 07 Nov 2022 | 615 | 32,105 (0%) | 0% | 22.7 | 13,991 | Common Stock |
| Avanos Medical Inc | Kerr W. Holbrook | SVP, GM Chronic Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.74 per share. | 09 May 2022 | 743 | 32,720 (0%) | 0% | 27.7 | 20,611 | Common Stock |
| Avanos Medical Inc | Kerr W. Holbrook | SVP, GM Chronic Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 12,949 | 33,463 (0%) | 0% | 0 | Common Stock |